Frank Angenstein Selected Research

Frank Angenstein Research Topics

5	Meningioma (Meningiomas) 01/2022 - 03/2013
2	Neoplasms (Cancer) 01/2020 - 03/2013
2	Cognitive Dysfunction 01/2019 - 07/2005
2	Seizures (Absence Seizure) 12/2017 - 10/2011
1	Hyperemia 01/2022
1	Hypoxia (Hypoxemia) 01/2020
1	Blindness (Hysterical Blindness) 04/2018
1	Synesthesia 04/2018
1	Paralysis (Palsy) 04/2018
1	Hearing Loss (Hearing Impairment) 04/2018
1	Demyelinating Diseases (Demyelinating Disease) 05/2014
1	Infarction (Infarctions) 02/2012
1	Cysts 01/2012
1	Status Epilepticus (Complex Partial Status Epilepticus) 07/2005
1	Epilepsy (Aura) 07/2005

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2011
2	Neurofibromin 2 (Merlin)IBA 01/2021 - 03/2013
2	temsirolimus FDA Link 01/2020 - 03/2013
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 03/2013
2	PotassiumIBA 02/2012 - 01/2012
1	Phosphotransferases (Kinase)IBA 01/2022
1	capivasertibIBA 01/2022
1	NAD (NADH)IBA 01/2022
1	Kruppel-Like Factor 4IBA 01/2020
1	Pentylenetetrazole (Metrazol)IBA 12/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	regorafenibIBA 01/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	Sorafenib (BAY 43-9006)FDA Link 01/2017
1	AntibodiesIBA 05/2014
1	ferric oxide (iron oxide)IBA 05/2014
1	AlbuminsIBA 05/2014
1	SilverIBA 05/2014
1	Bromodeoxyuridine (BrdU)IBA 03/2013
1	TOR Serine-Threonine KinasesIBA 03/2013
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 03/2013
1	Peptides (Polypeptides)IBA 03/2013
1	AntigensIBA 01/2012
1	ThalliumIBA 01/2012
1	Pilocarpine (Ocusert)FDA LinkGeneric 07/2005

1	Deep Brain Stimulation 01/2019
1	Therapeutics 04/2018